Andere talen CNBX Pharmaceuticals Inc.

Aandelen

CNBX

US13764M2098

Beurs gesloten - OTC Markets Andere beurzen 21:30:05 17-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,008 ^USD	-14,89%		0,00%	-43,66%

16/04	CNBX Pharmaceuticals Inc. rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 29 februari 2024	CI
12/01	CNBX Pharmaceuticals Inc. rapporteert winstresultaten voor het eerste kwartaal eindigend op 30 november 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	16/04
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	12/01
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	30/11
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	14-07-23
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)	05-06-23
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)	02-06-23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14-04-23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	14-04-23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	08-02-23
CNBX Pharmaceuticals Inc. Announces Board Resignations	08-02-23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	13-01-23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	13-01-23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	29-12-22
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc	29-12-22
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	30-11-22
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	30-11-22
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	30-11-22
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma	08-11-22
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.	08-11-22
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy	18-10-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen CNBX Pharmaceuticals Inc.

Aandelen

CNBX

US13764M2098

Andere talen

Filters